www.EXFILE.com 888.775-4789 -- BOSTON SCIENTIFIC CORP. FORM 8K
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): July 13,
2007
BOSTON
SCIENTIFIC CORPORATION
(Exact
name of registrant as specified in charter)
DELAWARE
|
1-11083
|
04-2695240
|
(State
or other
|
(Commission
|
(IRS
employer
|
jurisdiction
of
|
file
number)
|
identification
no.)
|
incorporation)
|
|
|
One
Boston Scientific Place, Natick,
Massachusetts
|
01760-1537
|
(Address
of principal executive offices)
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (508)
650-8000
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
On
July
13, 2007, Boston Scientific Corporation (the “Company”) announced that an
agreement had been reached to settle claims associated with a series of
product
communications issued by Guidant Corporation in 2005 and 2006. Boston Scientific
acquired Guidant Corporation last year.
Subject
to certain conditions, the Company will pay a total of $195
million. The agreement includes approximately 4,000 claims of
individuals that have been consolidated in the U.S. District Court for
the
District of Minnesota in a Multi-District Litigation, as well as an undetermined
number, but not all, of additional similar claims throughout the
country.
A
copy of
the press release is incorporated herein as Exhibit 99.1.
ITEM
9.01.
|
FINANCIAL
STATEMENTS AND EXHIBITS.
|
99.1
|
Press
release, dated July 13,
2007
|
SIGNATURE
Pursuant to
the
requirements of the Securities and Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
BOSTON
SCIENTIFIC
CORPORATION |
|
|
|
Date:
July 16, 2007 |
By: |
/s/ Lawrence
J.
Knopf |
|
Lawrence
J. Knopf |
|
Vice
President and Assistant General
Counsel
|
EXHIBIT
INDEX